Scan and contrast administration principles of MDCT

European Radiology, Supplement

Volumn 15, Issue 5, 2005, Pages

  Bae, Kyongtae Ty ^a   Heiken, Jay P ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Contrast media; MDCT; Optimization pharmacokinetics; Scan timing

Indexed keywords

CONTRAST MEDIUM; IODINATED CONTRAST MEDIUM; SODIUM CHLORIDE;

ARTICLE; BODY WEIGHT; CLINICAL PROTOCOL; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; HEART DISEASE; HEART OUTPUT; HUMAN; INJECTION; LIVER DISEASE; MULTIDETECTOR COMPUTED TOMOGRAPHY; PRIORITY JOURNAL; PROCESS OPTIMIZATION; RADIOLOGICAL TECHNOLOGIST; RADIOLOGIST; VELOCITY;

ANGIOGRAPHY; BODY WEIGHT; CARDIAC OUTPUT; CONTRAST MEDIA; HUMANS; INJECTIONS; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33644591714     PISSN: 16133749     EISSN: 16133757     Source Type: Journal    
DOI: 10.1007/s10406-005-0165-y     Document Type: Article

References (92)

1. Kormano M, Partanen K, Soimakallio S, Kivimaki T. Dynamic contrast enhancement of the upper abdomen: Effect of contrast medium and body weight. Investigative Radiology 1983; 18:364-367.
2. Heiken JP, Brink JA, McClennan BL, Sagel SS, Crowe TM, Gaines MV. Dynamic incremental CT: Effect of volume and concentration of contrast material and patient weight on hepatic enhancement. Radiology 1995; 195:353-357.
3. Platt JF, Reige KA, Ellis JH. Aortic enhancement during abdominal CT angiography: Correlation with test injections, flow rates, and patient demographics. AJR Am J Roentgenol 1999; 172:53-56.
4. Bae KT. Technical aspects of contrast delivery in advanced CT. Applied Radiology 2003; 32:12-19.
5. van Hoe L, Marchal G, Baert AL, Gryspeerdt S, Mertens L. Determination of scan delay time in spiral CT-angiography: Utility of a test bolus injection. J Comput Assist Tomogr 1995; 19:216-220.
6. Kirchner J, Kickuth R, Laufer U, Noack M, Liermann D. Optimized enhancement in helical CT: Experiences with a real-time bolus tracking system in 628 patients. Clin Radiol 2000; 55:368-373.
7. Bae KT, Heiken JP, Brink JA. Aortic and hepatic contrast medium enhancement at CT. Part II. Effect of reduced cardiac output in a porcine model. Radiology 1998; 207:657-662.
8. Dean PB, Violante MR, Mahoney JA. Hepatic CT contrast enhancement: effect of dose, duration of infusion, and time elapsed following infusion. Investigative Radiology 1980; 15:158-161.
9. Heiken JP, Brink JA, McClennan BL, Sagel SS, Forman HP, DiCroce J. Dynamic contrast-enhanced CT of the liver: Comparison of contrast medium injection rates and uniphasic and biphasic injection protocols. Radiology 1993; 187:327-331.
10. Chambers TP, Baron RL, Lush RM. Hepatic CT enhancement. Part I. Alterations in the volume of contrast material within the same patients. Radiology 1994; 193:513-517.
11. Kopka L, Rodenwaldt J, Fischer U, Mueller DW, Oestmann JW, Grabbe E. Dual-phase helical CT of the liver: Effects of bolus tracking and different volumes of contrast material. Radiology 1996; 201:321-326.
12. Han JK, Kim AY, Lee KY, et al. Factors influencing vascular and hepatic enhancement at CT: Experimental study on injection protocol using a canine model. J Comput Assist Tomogr 2000; 24:400-406.
13. Awai K, Hiraishi K, Hori S. Effect of contrast material injection duration and rate on aortic peak time and peak enhancement at dynamic CT involving injection protocol with dose tailored to patient weight. Radiology 2004; 230:142-150.
14. Bae KT, Heiken JP, Brink JA. Aortic and hepatic contrast medium enhancement at CT. Part I. Prediction with a computer model. Radiology 1998; 207:647-655.
15. Berland LL, Lee JY. Comparison of contrast media injection rates and volumes for hepatic dynamic incremented computed tomography. Investigative Radiology 1988; 23:918-922.
16. Small WC, Nelson RC, Bernardino ME, Brummer LT. Contrast-enhanced spiral CT of the liver: Effect of different amounts and injection rates of contrast material on early contrast enhancement. AJR Am J Roentgenol 1994; 163:87-92.
17. Freeny PC, Gardner JC, vonIngersleben G, Heyano S, Nghiem HV, Winter TC. Hepatic helical CT: Effect of reduction of iodine dose of intravenous contrast material on hepatic contrast enhancement. Radiology 1995; 197:89-93.
18. Han JK, Choi BI, Kim AY, Kim SJ. Contrast media in abdominal computed tomography: Optimization of delivery methods. Korean J Radiol 2001; 2:28-36.
19. Megibow AJ, Jacob G, Heiken JP, et al. Quantitative and qualitative evaluation of volume of low osmolality contrast medium needed for routine helical abdominal CT. AJR Am J Roentgenol 2001; 176:583-589.
20. Bae KT. Peak Contrast Enhancement in CT and MR Angiography: When Does It Occur and Why? Pharmacokinetic Study in a Porcine Model. Radiology 2003; 227:809-816.
21. Roos JE, Desbiolles LM, Weishaupt D, et al. Multi-detector row CT: effect of iodine dose reduction on hepatic and vascular enhancement. Rofo 2004; 176:556-563.
22. Garcia PA, Bonaldi VM, Bret PM, Liang L, Reinhold C, Atri M. Effect of rate of contrast medium injection on hepatic enhancement at CT. Radiology 1996; 199:185-189.
23. Bae KT, Heiken JP, Brink JA. Aortic and hepatic peak enhancement at CT: effect of contrast medium injection rate - pharmacokinetic analysis and experimental porcine model. Radiology 1998; 206:455-464.
24. Garcia P, Genin G, Bret PM, Bonaldi VM, Reinhold C, Atri M. Hepatic CT enhancement: Effect of the rate and volume of contrast medium injection in an animal model. Abdom Imaging 1999; 24:597-603.
25. Awai K, Takada K, Onishi H, Hori S. Aortic and hepatic enhancement and tumor-to-liver contrast: Analysis of the effect of different concentrations of contrast material at multi-detector row helical CT. Radiology 2002; 224:757-763.
26. Becker CR, Hong C, Knez A, et al. Optimal contrast application for cardiac 4-detector-row computed tomography. Invest Radiol 2003; 38:690-694.
27. Brink JA. Use of high concentration contrast media (HCCM): Principles and rationale-body CT. Eur J Radiol 2003; 45 Suppl 1:S53-58.
28. Fleischmann D. High-concentration contrast media in MDCT angiography: principles and rationale. Eur Radiol 2003; 13 Suppl 3:N39-43.
29. Fleischmann D. Use of high-concentration contrast media in multiple-detector-row CT: Principles and rationale. Eur Radiol 2003; 13 Suppl 5:M14-20.
30. Fleischmann D. Use of high concentration contrast media: Principles and rationale-vascular district. Eur J Radiol 2003; 45 Suppl 1:S88-93.
31. Shinagawa M, Uchida M, Ishibashi M, Nishimura H, Hayabuchi N. Assessment of pancreatic CT enhancement using a high concentration of contrast material. Radiat Med 2003; 21:74-79.
32. Awai K, Inoue M, Yagyu Y, et al. Moderate versus high concentration of contrast material for aortic and hepatic enhancement and tumor-to-liver contrast at multi-detector row CT. Radiology 2004; 233:682-688.
33. Furuta A, Ito K, Fujita T, Koike S, Shimizu A, Matsunaga N. Hepatic enhancement in multiphasic contrast-enhanced MDCT: Comparison of high- and low-iodine-concentration contrast medium in same patients with chronic liver disease. AJR Am J Roentgenol 2004; 183:157-162.
34. Suzuki H, Oshima H, Shiraki N, Ikeya C, Shibamoto Y. Comparison of two contrast materials with different iodine concentrations in enhancing the density of the the aorta, portal vein and liver at multi-detector row CT: A randomized study. Eur Radiol 2004; 14:2099-2104.
35. Yagyu Y, Awai K, Inoue M, et al. MDCT of hypervascular hepatocellular carcinomas: A prospective study using contrast materials with different iodine concentrations. AJR Am J Roentgenol 2005; 184:1535-1540.
36. Schoellnast H, Deutschmann HA, Fritz GA, Stessel U, Schaffler GJ, Tillich M. MDCT angiography of the pulmonary arteries: Influence of iodine flow concentration on vessel attenuation and visualization. AJR Am J Roentgenol 2005; 184:1935-1939.
37. Marchiano A, Spreafico C, Lanocita R, et al. Does iodine concentration affect the diagnostic efficacy of biphasic spiral CT in patients with hepatocellular carcinoma? Abdom Imaging 2005; 30:274-280.
38. Itoh S, Ikeda M, Achiwa M, Satake H, Ota T, Ishigaki T. Multiphase contrast-enhanced CT of the liver with a multislice CT scanner: Effects of iodine concentration and delivery rate. Radiat Med 2005; 23:61-69.
39. Cademartiri F, Mollet NR, van der Lugt A, et al. Intravenous contrast material administration at helical 16-detector row CT coronary angiography: Effect of iodine concentration on vascular attenuation. Radiology 2005; 236:661-665.
40. Hopper KD, Mosher TJ, Kasales CJ, TenHave TR, Tully DA, Weaver JS. Thoracic spiral CT: Delivery of contrast material pushed with injectable saline solution in a power injector. Radiology 1997; 205:269-271.
41. Dorio PJ, Lee FT, Jr., Henseler KP, et al. Using a saline chaser to decrease contrast media in abdominal CT. AJR Am J Roentgenol 2003; 180:929-934.
42. Haage P, Schmitz-Rode T, Hubner D, Piroth W, Gunther RW. Reduction of contrast material dose and artifacts by a saline flush using a double power injector in helical CT of the thorax. AJR Am J Roentgenol 2000; 174:1049-1053.
43. Irie T, Kajitani M, Yamaguchi M, Itai Y. Contrast-enhanced CT with saline flush technique using two automated injectors: How much contrast medium does it save? J Comput Assist Tomogr 2002; 26:287-291.
44. Schoellnast H, Tillich M, Deutschmann HA, et al. Abdominal multidetector row computed tomography: Reduction of cost and contrast material dose using saline flush. J Comput Assist Tomogr 2003; 27:847-853.
45. Cademartiri F, Mollet N, van der Lugt A, et al. Non-invasive 16-row multislice CT coronary angiography: Usefulness of saline chaser. Eur Radiol 2004; 14:178-183.
46. Schoellnast H, Tillich M, Deutschmann MJ, Deutschmann HA, Schaffler GJ, Portugaller HR. Aortoiliac enhancement during computed tomography angiography with reduced contrast material dose and saline solution flush: Influence on magnitude and uniformity of the contrast column. Invest Radiol 2004; 39:20-26.
47. Schoellnast H, Tillich M, Deutschmann HA, et al. Improvement of parenchymal and vascular enhancement using saline flush and power injection for multiple-detector-row abdominal CT. Eur Radiol 2004; 14:659-664.
48. Cademartiri F, Nieman K, van der Lugt A, et al. Intravenous contrast material administration at 16-detector row helical CT coronary angiography: Test bolus versus bolus-tracking technique. Radiology 2004; 233:817-823.
49. Bae KT. Test-bolus versus bolus-tracking techniques for CT angiographic timing. Radiology 2005; 236:369-370; author reply 370.
50. Yankelevitz DF, Shaham D, Shah A, Rademacker J, Henschke CI. Optimization of contrast delivery for pulmonary CT angiography. Clin Imaging 1998; 22:398-403.
51. Washington L, Gulsun M. CT for thromboembolic disease. Curr Probl Diagn Radiol 2003; 32:105-126.
52. Fleischmann D, Rubin GD. Quantification of intravenously administered contrast medium transit through the peripheral arteries: Implications for CT angiography. Radiology 2005; 236:1076-1082.
53. Bae KT, Heiken JP. Computer modeling approach to contrast medium administration and scan timing for multislice CT. In: Marincek B, Ros PR, Reiser M, Baker ME, eds. Multislice CT: A practical guide: Springer, 2000; 28-36.
54. Frederick MG, McElaney BL, Singer A, et al. Timing of parenchymal enhancement on dual-phase dynamic helical CT of the liver: How long does the hepatic arterial phase predominate? AJR Am J Roentgenol 1996; 166:1305-1310.
55. Foley WD, Kerimoglu U. Abdominal MDCT: Liver, pancreas, and biliary tract. Semin Ultrasound CT MR 2004; 25:122-144.
56. Hollett MD, Jeffrey RB, Jr., Nino-Murcia M, Jorgensen MJ, Harris DP. Dual-phase helical CT of the liver: Value of arterial phase scans in the detection of small (< or = 1.5 cm) malignant hepatic neoplasms. AJR Am J Roentgenol 1995; 164:879-884.
57. Oliver JH, 3rd, Baron RL. Helical biphasic contrast-enhanced CT of the liver: Technique, indications, interpretation, and pitfalls. Radiology 1996; 201:1-14.
58. Oliver JH, 3rd, Baron RL, Federle MP, Jones BC, Sheng R. Hypervascular liver metastases: Do unenhanced and hepatic arterial phase CT images affect tumor detection? Radiology 1997; 205:709-715.
59. Oliver JH, 3rd, Baron RL, Federle MP, Rockette HE, Jr. Detecting hepatocellular carcinoma: Value of unenhanced or arterial phase CT imaging or both used in conjunction with conventional portal venous phase contrast-enhanced CT imaging. AJR Am J Roentgenol 1996; 167:71-77.
60. Paulson EK, McDermott VG, Keogan MT, DeLong DM, Frederick MG, Nelson RC. Carcinoid metastases to the liver: Role of triple-phase helical CT. Radiology 1998; 206:143-150.
61. Mitsuzaki K, Yamashita Y, Ogata I, Nishiharu T, Urata J, Takahashi M. Multiple-phase helical CT of the liver for detecting small hepatomas in patients with liver cirrhosis: Contrast-injection protocol and optimal timing. AJR Am J Roentgenol 1996; 167:753-757.
62. Baron RL, Oliver JH, 3rd, Dodd GD, 3rd, Nalesnik M, Holbert BL, Carr B. Hepatocellular carcinoma: Evaluation with biphasic, contrast-enhanced, helical CT. Radiology 1996; 199:505-511.
63. Foley WD, Mallisee TA, Hohenwalter MD, Wilson CR, Quiroz FA, Taylor AJ. Multiphase hepatic CT with a multirow detector CT scanner. AJR Am J Roentgenol 2000; 175:679-685.
64. Lee KH, Choi BI, Han JK, Jang HJ, Kim TK, Han MC. Nodular hepatocellular carcinoma: Variation of tumor conspicuity on single-level dynamic scan and optimization of fixed delay times for two-phase helical CT. J Comput Assist Tomogr 2000; 24:212-218.
65. Murakami T, Kim T, Takamura M, et al. Hypervascular hepatocellular carcinoma: Detection with double arterial phase multi-detector row helical CT. Radiology 2001; 218:763-767.
66. Kanematsu M, Goshima S, Kondo H, et al. Optimizing scan delays of fixed duration contrast injection in contrast-enhanced biphasic multidetector-row CT for the liver and the detection of hypervascular hepatocellular carcinoma. J Comput Assist Tomogr 2005; 29:195-201.
67. Lim JH, Choi D, Kim SH, et al. Detection of hepatocellular carcinoma: value of adding delayed phase imaging to dual-phase helical CT. AJR Am J Roentgenol 2002; 179:67-73.
68. Lacomis JM, Baron RL, Oliver JH, 3rd, Nalesnik MA, Federle MP. Cholangiocarcinoma: Delayed CT contrast enhancement patterns. Radiology 1997; 203:98-104.
69. Tello R, Seltzer SE, Polger M, Spaulding S, Savci G. A contrast agent delivery nomogram for hepatic spiral CT. J Comput Assist Tomogr 1997; 21:236-245.
70. Bluemke DA, Fishman EK, Anderson JH. Dose requirements for a nonionic contrast agent for spiral computed tomography of the liver in rabbits. Invest Radiol 1994; 29:195-200.
71. Baker ME, Beam C, Leder R, Gulliver D, Paine SS, Dunnick NR. Contrast material for combined abdominal and pelvic CT: Can cost be reduced by increasing the concentration and decreasing the volume? AJR Am J Roentgenol 1993; 160:637-641.
72. Herts BR, Paushter DM, Einstein DM, Zepp R, Friedman RA, Obuchowski N. Use of contrast material for spiral CT of the abdomen: Comparison of hepatic enhancement and vascular attenuation for three different contrast media at two different delay times. AJR Am J Roentgenol 1995; 164:327-331.
73. Herts BR, O'Malley CM, Wirth SL, Lieber ML, Pohlman B. Power injection of contrast media using central venous catheters: Feasibility, safety, and efficacy. AJR Am J Roentgenol 2001; 176:447-453.
74. Walkey MM. Dynamic hepatic CT: How many years will it take 'til we learn? Radiology 1991; 181:17-18.
75. Brink JA, Heiken JP, Forman HP, Sagel SS, Molina PL, Brown PC. Hepatic spiral CT: Reduction of dose of intravenous contrast material. Radiology 1995; 197:83-88.
76. Yamashita Y, Komohara Y, Takahashi M, et al. Abdominal helical CT: evaluation of optimal doses of intravenous contrast material - a prospective randomized study. Radiology 2000; 216:718-723.
77. Kim T, Murakami T, Takahashi S, et al. Effects of injection rates of contrast material on arterial phase hepatic CT. AJR Am J Roentgenol 1998; 171:429-432.
78. Takeshita K. Prediction of maximum hepatic enhancement on computed tomography from dose of contrast material and patient weight: Proposal of a new formula and evaluation of its accuracy. Radiat Med 2001; 19:75-79.
79. Awai K, Hori S. Effect of contrast injection protocol with dose tailored to patient weight and fixed injection duration on aortic and hepatic enhancement at multidetector-row helical CT. Eur Radiol 2003; 13:2155-2160.
80. Claussen CD, Banzer D, Pfretzschner C, Kalender WA, Schorner W. Bolus geometry and dynamics after intravenous contrast medium injection. Radiology 1984; 153:365-368.
81. Harmon BH, Berland LL, Lee JY. Effect of varying rates of low-osmolarity contrast media injection for hepatic CT: Correlation with indocyanine green transit time. Radiology 1992; 184:379-382.
82. Chambers TP, Baron RL, Lush RM. Hepatic CT enhancement. Part II. Alterations in contrast material volume and rate of injection within the same patients. Radiology 1994; 193:518-522.
83. Tublin ME, Tessler FN, Cheng SL, Peters TL, McGovern PC. Effect of injection rate of contrast medium on pancreatic and hepatic helical CT. Radiology 1999; 210:97-101.
84. Hanninen EL, Vogl TJ, Felfe R, et al. Detection of focal liver lesions at biphasic spiral CT: Randomized double-blind study of the effect of iodine concentration in contrast materials. Radiology 2000; 216:403-409.
85. Shimizu T, Misaki T, Yamamoto K, Sueyoshi K, Narabayashi I. Helical CT of the liver with computer-assisted bolus-tracking technology: Scan delay of arterial phase scanning and effect of flow rates. J Comput Assist Tomogr 2000; 24:219-223.
86. Schoellnast H, Brader P, Oberdabernig B, et al. High-concentration contrast media in multiphasic abdominal multidetector-row computed tomography: Effect of increased iodine flow rate on parenchymal and vascular enhancement. J Comput Assist Tomogr 2005; 29:582-587.
87. Bader TR, Prokesch RW, Grabenwoger F. Timing of the hepatic arterial phase during contrast-enhanced computed tomography of the liver: assessment of normal values in 25 volunteers. Invest Radiol 2000; 35:486-492.
88. Kim T, Murakami T, Hori M, et al. Small hypervascular hepatocellular carcinoma revealed by double arterial phase CT performed with single breath-hold scanning and automatic bolus tracking. AJR Am J Roentgenol 2002; 178:899-904.
89. Mehnert F, Pereira PL, Trubenbach J, Kopp AF, Claussen CD. Biphasic spiral CT of the liver: Automatic bolus tracking or time delay? Eur Radiol 2001; 11:427-431.
90. Sandstede JJ, Tschammler A, Beer M, Vogelsang C, Wittenberg G, Hahn D. Optimization of automatic bolus tracking for timing of the arterial phase of helical liver CT. Eur Radiol 2001; 11:1396-1400.
91. Itoh S, Ikeda M, Achiwa M, Satake H, Iwano S, Ishigaki T. Late-arterial and portal-venous phase imaging of the liver with a multislice CT scanner in patients without circulatory disturbances: Automatic bolus tracking or empirical scan delay? Eur Radiol 2004; 14:1665-1673.
92. Bae KT. Contrast injection techniques and CT scan timing. In: Claussen CD, Fishman EK, Marincek B, Reiser M, eds. Multislice CT: A practical guide. Berlin: Springer, 2004; 121-128.